MedTrace Logo

Evaluating a New Stool Based qPCR for Diagnosis of Tuberculosis in Children and People Living With HIV

NCT05047315 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1967

Last updated 2026-03-06

No results posted yet for this study

Summary

Stool4TB aims to evaluate an innovative stool-based qPCR diagnostic platform (with the capacity to become a POC diagnostic tool) in the high TB and HIV burden settings of Mozambique, Eswatini and Uganda, under the hypothesis that it will narrow the extremely large TB case detection gap by improving TB confirmation rates in children and people living with HIV (PLHIV).

Conditions

Sponsors & Collaborators

  • Makerere University

    collaborator OTHER

  • Amsterdam Institute for Global Health and Development

    collaborator OTHER

  • Centro de Investigacao em Saude de Manhica

    collaborator OTHER

  • Baylor Eswatini Clinical Centre of Excellence (COE)

    collaborator UNKNOWN

  • Research Center Borstel

    collaborator OTHER

  • Fundação Manhiça

    collaborator OTHER

  • Baylor College of Medicine

    collaborator OTHER

  • Barcelona Institute for Global Health

    lead OTHER

Principal Investigators

  • Alberto L García-Basteiro, MD, PhD · Barcelona Institute for Global Health

  • Elisa López Varela, MD, PhD · Barcelona Institute for Global Health

Eligibility

Min Age
0 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2024-12-17
Completion
2025-06-30

Countries

  • Eswatini
  • Mozambique
  • Uganda

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05047315 on ClinicalTrials.gov